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Introduction 
The development of rapid, non-invasive methods of screening for volatile organic 
compounds (VOCs) in breath has potential in a number of different areas. Areas of 
interest include point-of-care medical diagnostics, for example determining narcotic 
and alcohol intoxication [1], and food chemistry, as a method of monitoring aroma 
compounds and flavor release [2]. There are a number of different technologies 
available for these applications including ion mobility spectrometry [3], chemical 
sensors (e.g. electronic nose) [4] and spectroscopic methods such as Fourier 
transform infrared spectroscopy [5]. All of these technologies have the potential to be 
easily miniaturized and work in the field or point-of-care settings. However, 
limitations exist in that they may be specific to a particular group of target 
compounds or suffer background interferences through low resolution. 
 Mass spectrometry (MS) has the potential to obtain higher resolution data and 
enables straightforward identification of a compound by its mass to charge ratio 
(m/z). Gas chromatography-MS (GC-MS) has for many years been the technique of 
choice for breath analysis [6]. GC-MS can offer high chromatographic resolution and 
is readily coupled to pre-concentration techniques such as thermal desorption [7] 
(TD) or needle trap devices [8] which enable trace level VOCs in breath to be 
focused to detectable levels prior to analysis. Trapping on adsorbent tubes or storing 
samples in Tedlar bags allows samples to be collected at a remote location and later 
returned to the laboratory for analysis. Furthermore, the availability of GC compound 
libraries aid in the identification of VOCs present in breath samples. However this 
approach has its limitations, due to the inherent complexity of breath samples the 
chromatographic separation often requires long run times (30-60 min) making the 
technique ill-suited to high-throughput screening of large numbers of individuals. In 
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addition, subtle chemical changes may occur during transport and/or storage time [9] 
and thus some information may be lost. Moreover, the equipment required for GC-
MS tends to be large, bulky and laboratory based that requires operation by 
specialist users. 
The limitations of GC-MS have been partly resolved with the development of 
techniques such as proton transfer reaction-MS [10] and selected ion flow tube-MS 
(SIFT-MS) [11] for breath analysis. These approaches are capable of monitoring 
highly volatile species in breath in real-time, providing immediate diagnostic data 
with sub part per billion levels of sensitivity without the requirement for pre-
concentration procedures. SIFT-MS, in particular, has successfully demonstrated 
quantitative potential for breath analysis as single reactant ion species can be 
selected, thus simplifying the ion chemistry in the source.  This has been employed 
for a range of different compounds in breath such as acetaldehyde, ammonia and 
isoprene [12,13]. Although more compact versions of these instruments have been 
developed, they remain heavy and not suited to transportation between laboratories 
and/or into the field.  
 Interfacing of exhaled breath sampling to MS using ambient ionization 
techniques such as extractive electrospray ionization [14-18], atmospheric pressure 
chemical ionization (APCI-MS) [19-21] and glow discharge [22] has also been 
accomplished. These approaches can be readily interfaced to mass spectrometers 
with atmospheric pressure ionization sources to allow analysis of volatiles. APCI-MS 
has proven very effective in determining volatile species, notably being used to 
detect aroma compounds released from food while eating [19-21]. This work led to 
the development of the MS-nose interface where a coaxial Venturi interface was 
used to produce a commercial volatile analysis source [23]. Outside of food analysis, 
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on-line breath analysis using APCI-MS has been shown to be a sensitive method for 
determining narcotics in breath [24]. However, potential use of these equipment in 
the field is limited due to their size, cost and the requirement for climate controlled 
laboratories and expert users.  
 In recent years there has been interest in smaller, portable mass 
spectrometers. These instruments, albeit with some reduction in sensitivity of larger 
laboratory based mass spectrometers, have a far smaller footprint and lower cost 
while maintaining most of their functionality. This reduction in size potentially comes 
at the cost of a reduction in the m/z scan range of the instruments. However, these 
losses usually occur in the higher m/z regions and, therefore, do not affect the 
application of breath analysis to a great extent. Setup and running times are reduced 
in comparison to full-sized instrumentation, affording their use as mobile 
instrumentation. Recently, a number of instruments have been commercially 
released and have been demonstrated for a number of different applications 
including on-line flow chemistry [25] and phytochemical screening [26].  
 Here we demonstrate the coupling of exhaled breath analysis to an Advion 
Expression compact mass spectrometer (CMS) using an in-house designed and 
custom manufactured Venturi jet pump interface. Previous reports have evaluated 
the suitability of instrumental development through an induced fluctuation in a breath 
metabolite [27,28]. Therefore, we asked participants to ingest a commercially 
available peppermint oil capsule allowing subsequent release of VOCs for 
measurement in the breath. The emanation and elimination of menthone was 
monitored, and an established GC-MS method was employed for comparison. The 
aims of this preliminary communication were to demonstrate that versatile, low-cost 
and fieldable instrumentation can, with a simple modification, be used to monitor 
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volatile compounds in the breath, and to show the potential of portable mass 
spectrometers for high sensitivity on-line breath analysis at the point-of-care.  
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Methods & materials/Experimental 
Instrumentation 
A full-face breathing mask (Resmed, Abingdon, UK) fitted with a one-way, non-
rebreathable valve (Clement Clarke, Harlow, UK) was interfaced into the APCI 
source gas line of an Advion Expression CMS using an in-house constructed Venturi 
jet pump (Albrook Engineering, Loughborough UK) (Figure 1). The mask was 
connected to the Venturi pump using a 60 cm length of 1/8” O.D. 1/16” I.D PTFE 
tubing and the pump and tubing assembly was heated to 100 °C using a 
thermostatically controlled rope heater (Omega, Manchester, UK). The jet pump 
emitter consisted of a laser drilled glass lens (Bird Precision, Waltham, MA, USA, 
PN: RB-24010-.008) with an orifice size of 203 µm. The pump throat involved a 4 
mm diameter narrowing to a 1.5 mm tube. The instrument was operated in positive 
ionization mode for all experiments. The air supply to the mask passed through a 
Balston DX, BX and Cl triple filter system to remove particulate and hydrocarbon 
interferences. The pre-conditioned air was supplied to the mask at 20 L/min in order 
to provide adequate air flow for participants to ventilate comfortably. The APCI gas 
was set at 4 L/min which gave a measured suction from the mask of 260 mL/min. 
The transport time from the mask to the ion source using this system was <1 s. 
Breath profiles were monitored both with the mass spectrometer and with a pressure 
transducer system [29]. The CMS ion source parameters were optimized using a 
menthol vapor source prior to analysis and the optimized conditions were as follows: 
capillary temperature 250 °C, capillary voltage 42 V, source voltage 15 V, APCI gas 
temperature 40 °C, corona discharge voltage 5 kV. All spectra were acquired over a 
range between m/z 30-300 at a scan rate of 1 scan per 300 ms. The Expression 
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CMS gives a resolving power of 0.5 to 0.7 m/z units (FWHM) at 1000 m/z units/s 
over the acquisition range. 
Sampling 
Sixteen healthy volunteers were recruited for this study (7 male and 9 female over an 
age range from 22 to 53 years). All procedures were approved by the local ethical 
advisory board and participants provided written informed consent prior to the 
initiation of the study. All study protocols complied with the Declaration of Helsinki. 
 Prior to sampling, breath masks were disinfected using Milton solution 
followed by overnight conditioning in a vacuum oven at 50 °C. Each individual reused 
a single breath mask to ensure no transfer of infectious material or cross 
contamination between participants occurred. The participant was asked to breathe 
at a normal rate and depth and a 2 min equilibration time was performed prior to data 
acquisition. This familiarization allowed for any abnormal breathing patterns to 
subside and laboratory air contaminations to clear the system. Sample data points 
were collected for 3 min during which mass spectral data and pressure transducer 
breath profiles were acquired. Each participant was asked to arrive to the laboratory 
during the morning after an overnight fast and provided a blank breath sample (0 
min) before ingesting a commercially available 200 mg peppermint oil capsule 
(Boots, Nottingham, UK). Subsequent breath samples were recorded at 60, 120, 240 
and 360 min post-ingestion (study 1). Additionally, an extended experiment was 
performed where breath samples were taken at 0, 180, 240, 360, 480 and 600 min 
(n=4) using 1 female and 3 male participants from the original study with ages 
ranging between 26 and 36 years (study 2). 
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 Finally, continuous real-time monitoring was conducted by a single participant. 
The individual exhaled at a normal depth and rate into the mask for 20 min post-
ingestion of a peppermint oil capsule and data was continuously acquired (study 3). 
Statistical analyses 
Statistical analyses were performed using IBM SPSS Statistics (v22, IBM Corp., 
Armonk, NY, USA). Wilcoxon signed rank tests were performed to assess the 
changes in intensity of the exhaled ion m/z 137 and 155 (as ions of menthone) over 
time in comparison to baseline (0 min) measurements. All p values described in this 
manuscript refer to their Bonferroni adjusted values for multiple comparisons. An 
adjusted p value of <0.05 was deemed as statistically significant. 
 
Comparison with GC-MS 
Prior to commencement of participant sampling, a pilot experiment was conducted in 
order to estimate the potential levels of menthone in exhaled breath using a 
previously validated method [29]. Exhaled VOCs were collected from 2 L of breath 
prior to and at 73, 174, 415 and 600 min post-ingestion of the peppermint oil 
capsule. Samples were collected on a dual-bed TD tube (Tenax:Carbograph TD, 
Markes Int., UK) and analyzed using thermal desorption (Unity 2, Markes Int., UK)-
gas chromatography (Agilent 7890, Wokingham, UK)-mass spectrometry (Agilent 
5977A quadrupole mass spectrometer, Wokingham, UK) (TD-GC-MS) (study 4). 
Sample chromatograms were processed for the presence and intensity of m/z 112 
(base peak of menthone for electron ionization) and an elimination curve was 
created. Levels of menthone and the period of wash out for these from the human 
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biological system were assessed. Standard calibration analyses for menthone 
(Sigma-Aldrich, Gillingham, UK) were performed and quantitative values were 
obtained for each sample time point.  
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Results & discussion 
Accumulation and washout (Study 1 and 2) 
Breath samples taken from participants at 0 min were all shown to contain the 
[M+H]+ ion of acetone at m/z 59 as the base peak. In addition to the acetone 
monomer, a water cluster of acetone [acetone+H2O+H]+ and proton-bound dimer 
[2acetone+H]+ were observed at m/z 77 and 117, respectively (Figure 2). The 
presence of acetone in the sample was expected since acetone is a major breath 
metabolite [30]. The concentration of acetone observed in the breath can be affected 
by a range of different factors such as diet, fasting and clinical state, and there been 
a wide range of studies conducted which have measured breath acetone. Smith et 
al. reported concentrations between 200 to 600 parts per billion by volume (ppbv) in 
healthy individuals following consumption of a liquid protein-calorie meal after a 12 hr 
fast [31]. Clinical factors such as diabetes can result in elevated acetone levels, and 
a study by Wang et al. showed that breath acetone levels in type 1 diabetic patients 
were significantly higher than in healthy volunteers (2.19 versus 0.48 ppm in 
diabetics and healthy controls, respectively) [32]. Ions relating to acetone were 
detectable from a single breath in all of the healthy participants tested in this study 
demonstrating sensitivity in the ppbv range.  
 The breathing profile of each participant could be clearly observed in the total 
ion trace (Figure 3), where each peak demonstrated an increase in ion counts at the 
onset of exhalation, a plateau during steady-state exhalation and a reduced ion 
count at the cessation of exhalation and beginning of inhalation. This breathing 
profile followed an identical pattern to that seen in the pressure trace measured from 
the breathing mask (Figure 4). 
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 Three notable peaks were additionally detected in the breath post-ingestion, 
with m/z values of 81, 137 and 155 (Figure 5). The peak observed at m/z 155 
corresponds to the [M+H]+ ion of menthone, a major component of peppermint oil. 
The most intense of the peaks resulting from peppermint oil dosing was at m/z 137. 
This ion is a known diagnostic fragment ion for oxygenated terpenes and can arise 
from a number of different sources such as loss of water from the protonated 
menthone or protonation of monoterpene hydrocarbons, such as α- and β-pinene 
[33]. The identity of the m/z 81 peak is [C6H8+H]+ which has shown to be a common 
ion from monoterpene fragmentation [34]. Analysis of a 1:100 dilution of a menthone 
standard in water by APCI-MS demonstrated that the m/z 137 ion is one of the main 
peaks in the mass spectrum (Figure S1), suggesting that a potential source of the 
m/z 137 ion is water loss from protonated menthone. The contribution of menthone 
([M+H]+) fragmentation to m/z 137 can be approximated using the ratio of m/z 
137:m/z 155 obtained from Figure S1. This shows a ratio of 1.59:1 in favor of the m/z 
155 ion. Applying this ratio to the data shown in Figure 5 suggests that ~10% of the 
m/z 137 response is generated via this route, and that ~90% of the m/z 137 peak is 
from monoterpene species present in the breath. 
 Wash out profiles were obtained for m/z 137 and the menthone [M+H]+ ion 
(m/z 155). Two distinct wash out profiles were observed for both ions. In study 1, 12 
participants saw a rise in the intensity of the exhaled peppermint oil components at 
60 min post-ingestion, before decreasing exponentially over the sampling time 
period. Alternatively, delayed peak intensity was observed in 4 participants showing 
a maximal ion response at 120 min, reducing to similar levels as the main group by 
240 to 360 min. Figure 6 illustrates the emanation and elimination profiles for m/z 
137 and 155. A comparable rise and fall of the ions, albeit with a delayed 
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component, can be clearly depicted for the main set (n=12) and subset (n=4) of 
participants. The mechanistic underpinning for the presence of alternative profiles is 
unknown but may be due to variances in capsule breakdown rates in the stomach, or 
biological variations in molecule absorption/processing. For participants not showing 
a delayed maximal intensity, ion intensities for m/z 137 were increased at 60 min 
(p=0.008) and remained above baseline (0 min) levels for the entirety of the 
sampling period (p≤0.009), with ion intensities of the m/z 155 increased at 60 and 
120 min (p≤0.020) and returning to baseline levels by 240 min (p>0.05). No 
statistical increases were reported in the delayed ion response group, due to 
underpowered analyses with n=4. Power calculations to report a significant 
difference at 60 min compared to baseline for a power of 80% and a p value of <0.05 
indicate a sample group of n=13 would be required. When the two groups were 
combined, exhaled levels of m/z 137 remained above baseline values past 360 min 
post-ingestion (p≤0.004) and remained above baseline values for m/z 155 until 120 
min post-ingestion (p’s=0.004) returning to baseline by 240 min post-ingestion 
(p>0.05).  
 Samples taken for up to 10 hrs (600 min, study 2) after ingestion of the 
peppermint oil capsule showed further decrease of m/z 137 over time, with median 
values remaining above baseline throughout (data not shown). Statistically different 
levels were not observed in this cohort, again due to underpowered analyses with 
n=4. Final elimination of the peppermint oil compounds and a return to baseline 
values was predicted at approximately 10.5 to 11 hrs post-ingestion.  
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Real-time monitoring (study 3) 
The continuous real-time measurement of the evolution of peppermint oil from the 
breath showed an increase in m/z 137 response after approximately 10-13 min post-
ingestion. This increase can be attributed to the release of menthone and other 
monoterpene species from the ingested tablet. Previous work has reported a 
reduction in exhaled menthone after 5 min of breathing synthetic air, remaining at the 
reduced levels for up to 30 min [35]. This continued to increase toward the end of the 
sampling period (Figure 7). The large intensity peak at 7 min corresponds to 
involuntary eructation producing a large response of the ion. This occurs due to the 
breakdown of the capsule in the stomach, followed by an uncontrolled reflux of 
stomach gases containing high levels of peppermint oil components. Based on the 
data obtained from the 6 hr (360 min) experiments, the intensity of the m/z 137 is 
expected to further increase before reaching its peak intensity. This observation 
highlights the suitability of this method for the application of real-time breath analysis 
and shows the potential for on-line analysis of the metabolism of components 
released after digestion.  
 
TD-GC-MS wash out (study 4) 
A linear calibration was performed on menthone spiked onto TD tubes over a range 
from 0 to 8 ng on-column mass (OCM) and an excellent linear response was 
obtained (Figure S2). A washout experiment was performed on a single participant 
with samples taken at five points (t = 0, 74, 174, 415 and 600 min). Figure S3 shows 
that menthone was observed in the exhaled breath at all sampling time points, 
including the baseline sample prior to ingestion of the capsule.  The pre-ingestion 
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sample displayed an OCM of 0.112 ng (corresponding to 56 pg/L exhaled breath) 
and increased 7-fold to 0.771 ng OCM at 74 min (corresponding to 386 pg/L exhaled 
breath). This concentration then dropped over time and reduced to near baseline 
levels of 0.166 and 0.131 ng OCM at 415 and 600 min, respectively. An overlay of 
the extracted ion responses for the menthone fragment ion at m/z 112 is shown in 
Figure S4 to enable visual comparison of the peak area response obtained for 
menthone at each time point. 
 Comparison with the obtained calibration indicated that the concentration of 
menthone in the breath at the 120 min time point was approximately 55 parts per 
trillion by volume (pptv, see electronic supplementary information for calculations). 
The menthone [M+H]+ ion at m/z 155 is clearly observable in the APCI-MS washout 
profiles at this point. This observation highlights that the compact mass spectrometer 
with direct APCI analysis has great potential as a sensitive in-clinic breath analyzer. 
 The data obtained from the Venturi pump interface here compares well with 
the commercially available MS-Nose interface. The MS-Nose is typically used for the 
analysis of flavor compounds in the breath which has been stated as being in the low 
ppbv range [19]. A study by Avison [36] compared the quantitative performance of 
the APCI-MS MS-Nose fitted to a quadrupole mass spectrometer, with an Ionicon 
PTR-MS system, for 7 different test compounds (2-butanone, E-2-hexenol, hexanoic 
acid, benzaldehyde, 2,3 DMP, ethyl butyrate and amyl acetate) from the headspace 
of aqueous solutions. The MS-Nose system obtained limits of detection ranging from 
0.1 ppbv for benzaldehyde to 9.1 ppbv for 2-butanone. The demonstrated sensitivity 
for menthone at 120 min (51 pptv) in this study indicates that the system described 
here compares favorably with the commercial bench top MS system with the MS-
Nose interface. In addition, the system demonstrated in this report can be interfaced 
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into any APCI-MS source and does not require permanent modification to the APCI 
probe. 
Conclusions 
This study shows the first application of a portable APCI-MS instrument to the real-
time profiling of a pseudo-metabolite in breath and its comparison with the gold 
standard GC-MS technique in a parallel experiment. A major limitation restricting 
clinical breath analysis is the inability to easily transport and set up sensitive 
instrumentation at the point-of-care. The use of a CMS with a modified APCI inlet 
demonstrates a portable and rapidly deployable answer to overcome this challenge. 
The combination of the vapor introduction interface with the APCI-MS is shown to be 
capable of detecting breath metabolites, such as acetone, with good levels of 
sensitivity. The introduction of an artificial change in the breath profile to act as 
pseudo-biomarker was accomplished by ingestion of a peppermint oil capsule. The 
data obtained from this experiment illustrates that this system can detect changes in 
exhaled breath profiles both in real-time and across an extended time period, with 
differences observed in breath profiles for up to 10 hrs after ingestion of the 
peppermint oil capsule. Comparative data obtained by TD-GC-MS suggests that the 
APCI-MS approach using the CMS is highly sensitive and capable of detecting 
peppermint oil compounds at levels in the low pptv range. The modified 
instrumentation was demonstrated as capable for measurement in real-time through 
the continuous monitoring of an induced metabolic change in the breath, in a manner 
similar to flavor release experiments reported by Linforth and Taylor [19-21].  
 These data show that direct, high-sensitivity measurements from breath are 
possible using a portable mass spectrometer with a simple and straightforward 
modification to the APCI gas inlet line, using the standard APCI source. The 
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instrumentation used in this study is low cost, lightweight and the results obtained 
show that trace levels of a VOC in the breath can be detected, highlighting its 
suitability for metabolite monitoring. The APCI inlet modification described in this 
report can be installed/removed as required, allowing for the instrumentation to be 
employed for multiple sample mediums at the discretion of the analyst.  Furthermore, 
the combination of breath analysis with the portable mass spectrometer has the 
potential to be used as a deployable instrument (i.e. on a portable trolley) which can 
be quickly setup in a clinical research environment, or at a remote location and used 
to carry out in-situ breath tests.   
 18 
 
Future Perspective: 
Future development of compact mass spectrometers poses exciting possibilities in 
the rapid on-line analysis of health and disease. On-line analysis has the potential to 
monitor targeted breath metabolites in a continuous manner that can be utilized for 
health observations in a clinical setting. Therefore, the completion of extended 
experiments similar to that described in this report would be beneficial. It is also of 
great interest to be able to accurately quantitate exhaled metabolites using this 
technique. In order to overcome complex ion chemistries in the APCI source, future 
developments incorporating stable isotope labelled internal standards are required. 
With commercialization of exhaled breath sampling devices coupled to purpose built 
portable compact mass spectrometer units, the ability to sample patients at the point-
of-care is a real possibility. Furthermore, the technology is perfectly amenable to be 
adapted for use away from disease scenarios such as rapid assessment of exhaled 
breath profiles for everyday life or sporting situations. Perhaps in 10 years from now 
we will see these devices used to assess general health status/diagnose disease-
onset in public hospitals and/or general practitioners’ surgeries. 
 
Executive Summary: 
Background 
• Analysis of exhaled breath volatiles has gained interest in recent years as a 
method to assess biological processes. 
• The ability to miniaturize and simplify analytical instrumentation is desirable 
for on-line, point-of-care analysis. 
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Experimental 
• An in-house designed interface allowed for the coupling of a full-face breath 
mask to an Advion Expression compact mass spectrometer. 
• Volunteers provided exhaled breath samples prior to and on several 
occasions post-ingestion of a commercially available peppermint oil capsule. 
Results & Discussion 
• Ions related to the breakdown of the peppermint capsule were detected in 
elevated levels at 60-120 min post-ingestion. 
• A wash-out profile of the peppermint oil related ions was observed and 
menthone was detectable at levels above baseline at 360 min post-ingestion. 
• Detectable levels were comparable to previously validated GC-MS methods in 
the range of parts per trillion by volume. 
Conclusion 
• A straightforward modification using the standard APCI source allowed for 
high sensitivity measurements of exhaled breath volatiles on a portable 
compact mass spectrometer, with potential use in clinical and other non-
laboratory based scenarios.    
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Figure Captions 
 
Figure 1. Schematic drawing illustrating the modification to the APCI gas line to 
incorporate a heated Venturi pump and full face breathing mask to allow analysis of 
exhaled gases via APCI-MS using a compact mass spectrometer. 
Note: APCI-MS = atmospheric pressure chemical ionization-mass spectrometry 
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Figure 2. Averaged APCI-MS mass spectrum across a 3 min sampling period for 
one participant prior to ingestion of the peppermint oil capsule. 
Note: APCI-MS = atmospheric pressure chemical ionization-mass spectrometry; IR = 
relative intensity; m/z = mass to charge ratio 
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Figure 3. Example total ion trace for one participant over a 3 min sampling period 
(bottom) with expanded view of four breaths (top) to show the total ion response 
corresponding to (i) the increased exhalation at the beginning of the breath, (ii) 
steady-state exhalation during the middle portion of breath and (iii) the cessation of 
exhalation and onset of inhalation toward the final stage of the breath. 
Note: IR = relative intensity; t = time  
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Figure 4. Example pressure trace of the full face breathing mask (top – dotted line) 
and the time-matched total ion response from the compact mass spectrometer 
(bottom – solid line). Each peak corresponds to one breath and shows a matching 
response of breathing profile from both sampling modalities. 
Note: IR = relative intensity; t = time 
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Figure 5. Averaged APCI-MS mass spectrum across a 3 min sampling period for 
one participant at 60 min post-ingestion of the peppermint oil capsule. 
Note: APCI-MS = atmospheric pressure chemical ionization-mass spectrometry; IR = 
relative intensity; m/z = mass to charge ratio 
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Figure 6. Extracted ion response for all participants stratified by common (solid line, 
n=12) and delayed (dashed lined, n=4) maximal intensities of m/z 137 (top) and m/z 
155 (bottom) from prior to and up to 360 min post-ingestion of the peppermint oil 
capsule. Plotted points refer to the median value and error bars to the interquartile 
range. # p≤0.020 
Note: I = intensity; t = time  
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Figure 7. Extracted ion trace for m/z 137 in one participant for 20 min immediately 
post-ingestion of the peppermint oil capsule. Large peak intensity seen at 7 min 
corresponds to involuntary eructation. The inset shows the steady increase in m/z 
137 observed between 10 to 20 min. 
Note: I = intensity; t = time 
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Figure S1. APCI-MS spectrum of the volatile headspace from a 1.0% menthone 
solution in HPLC grade water. 
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Figure S2. External calibration for the m/z 112 fragment ion of menthone from the 
GC-MS analysis of liquid standards spiked on Tenax/Carbograph TD tubes 
displaying 95% confidence limits (dotted red lines). 
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Figure S3. Graph showing the intensity of the m/z 112 ion (menthone fragment) 
obtained by TD-GC-MS against time over a 600 min time course post-ingestion of a 
peppermint oil capsule. 
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Figure S4. Overlaid TD-GC-MS extracted ion traces for the m/z 112 fragment ion of 
menthone from each of the 5 sampling points of the 600 min washout experiment. 
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 Calculations 
From Figure S2 at 120 minutes the peak area response for m/z 112 is calculated by: 
 
y = 0.1661x2 - 203.39x + 66382 
y = (0.1661 * 1202) – (203.30 * 120) + 66382 
y = 2391.84 – 24396 + 66382       
Peak area response at 120 minutes  = 44378 cps 
 
On-column mass (OCM) is found by extrapolating this from the calibration graph 
(Figure S2) (rearranging y = mx+c) gives: 
44378 + 3950.9 / 69885 
OCM = 0.692 ng 
 
2 litres of breath were collected therefore the concentration of menthone per litre was 
0.346 ng/L 
 
Conversion to ppbv was accomplished using the following equation. 
 
Concentration in ppbv = (concentration in ng/L x 24.45) / relative molecular mass 
Please note:  
 1 M of gas expands to fill 24.45 L at normal temperature (25 ºC) and pressure (1 
atm) 
RMM of menthone = 154 amu 
 
Concentration ppbv = (0.346 x 24.45) / 154  
= 0.0549 ppbv = 54.9 pptv 
 
Menthone concentration at 120 minutes = 54.9 pptv 
